NovoCure Ltd Insider Trading for December 2020
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in NovoCure Ltd.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in NovoCure Ltd for December 2020.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 22 2020 | NVCR | NovoCure Ltd | Benaim Ely | Chief Medical Offic ... | Option Exercise | M | 83.30 | 651 | 54,228 | 4,555 | |
| Dec 22 2020 | NVCR | NovoCure Ltd | Benaim Ely | Chief Medical Offic ... | Option Exercise | M | 47.56 | 1,833 | 87,177 | 12,831 | |
| Dec 22 2020 | NVCR | NovoCure Ltd | Benaim Ely | Chief Medical Offic ... | Sell | S | 156.71 | 651 | 102,018 | 29,356 | 30 K to 29.4 K (-2.17 %) |
| Dec 22 2020 | NVCR | NovoCure Ltd | Benaim Ely | Chief Medical Offic ... | Buy | M | 83.30 | 651 | 54,228 | 30,007 | 29.4 K to 30 K (+2.22 %) |
| Dec 22 2020 | NVCR | NovoCure Ltd | Benaim Ely | Chief Medical Offic ... | Sell | S | 156.71 | 1,833 | 287,249 | 29,356 | 31.2 K to 29.4 K (-5.88 %) |
| Dec 22 2020 | NVCR | NovoCure Ltd | Benaim Ely | Chief Medical Offic ... | Buy | M | 47.56 | 1,833 | 87,177 | 31,189 | 29.4 K to 31.2 K (+6.24 %) |
| Dec 22 2020 | NVCR | NovoCure Ltd | HILLEMAN JERYL L | Director | Sell | S | 166.40 | 2,500 | 416,000 | 3,400 | 5.9 K to 3.4 K (-42.37 %) |
| Dec 22 2020 | NVCR | NovoCure Ltd | Danziger Asaf | Chief Executive Off ... | Option Exercise | M | 22.00 | 103,955 | 2,287,010 | 0 | |
| Dec 22 2020 | NVCR | NovoCure Ltd | Danziger Asaf | Chief Executive Off ... | Option Exercise | M | 22.00 | 103,955 | 2,287,010 | 103,955 | |
| Dec 22 2020 | NVCR | NovoCure Ltd | Danziger Asaf | Chief Executive Off ... | Sell | S | 166.08 | 400 | 66,432 | 197,632 | 198 K to 197.6 K (-0.20 %) |
| Dec 22 2020 | NVCR | NovoCure Ltd | Danziger Asaf | Chief Executive Off ... | Sell | S | 164.96 | 971 | 160,175 | 198,032 | 199 K to 198 K (-0.49 %) |
| Dec 22 2020 | NVCR | NovoCure Ltd | Danziger Asaf | Chief Executive Off ... | Sell | S | 163.35 | 536 | 87,555 | 199,003 | 199.5 K to 199 K (-0.27 %) |
| Dec 22 2020 | NVCR | NovoCure Ltd | Danziger Asaf | Chief Executive Off ... | Sell | S | 162.35 | 1,700 | 276,000 | 199,539 | 201.2 K to 199.5 K (-0.84 %) |
| Dec 22 2020 | NVCR | NovoCure Ltd | Danziger Asaf | Chief Executive Off ... | Sell | S | 161.11 | 4,014 | 646,679 | 201,239 | 205.3 K to 201.2 K (-1.96 %) |
| Dec 22 2020 | NVCR | NovoCure Ltd | Danziger Asaf | Chief Executive Off ... | Sell | S | 160.27 | 11,686 | 1,872,915 | 205,253 | 216.9 K to 205.3 K (-5.39 %) |
| Dec 22 2020 | NVCR | NovoCure Ltd | Danziger Asaf | Chief Executive Off ... | Sell | S | 159.27 | 4,790 | 762,903 | 216,939 | 221.7 K to 216.9 K (-2.16 %) |
| Dec 22 2020 | NVCR | NovoCure Ltd | Danziger Asaf | Chief Executive Off ... | Sell | S | 158.06 | 10,077 | 1,592,811 | 221,729 | 231.8 K to 221.7 K (-4.35 %) |
| Dec 22 2020 | NVCR | NovoCure Ltd | Danziger Asaf | Chief Executive Off ... | Sell | S | 157.01 | 23,601 | 3,705,522 | 231,806 | 255.4 K to 231.8 K (-9.24 %) |
| Dec 22 2020 | NVCR | NovoCure Ltd | Danziger Asaf | Chief Executive Off ... | Sell | S | 156.08 | 24,973 | 3,897,861 | 255,407 | 280.4 K to 255.4 K (-8.91 %) |
| Dec 22 2020 | NVCR | NovoCure Ltd | Danziger Asaf | Chief Executive Off ... | Sell | S | 155.23 | 21,207 | 3,292,005 | 280,380 | 301.6 K to 280.4 K (-7.03 %) |
| Dec 22 2020 | NVCR | NovoCure Ltd | Danziger Asaf | Chief Executive Off ... | Buy | M | 22.00 | 103,955 | 2,287,010 | 301,587 | 197.6 K to 301.6 K (+52.60 %) |
| Dec 22 2020 | NVCR | NovoCure Ltd | Danziger Asaf | Chief Executive Off ... | Sell | S | 166.17 | 200 | 33,234 | 197,632 | 197.8 K to 197.6 K (-0.10 %) |
| Dec 22 2020 | NVCR | NovoCure Ltd | Danziger Asaf | Chief Executive Off ... | Sell | S | 165.38 | 700 | 115,768 | 197,832 | 198.5 K to 197.8 K (-0.35 %) |
| Dec 22 2020 | NVCR | NovoCure Ltd | Danziger Asaf | Chief Executive Off ... | Sell | S | 164.11 | 500 | 82,055 | 198,532 | 199 K to 198.5 K (-0.25 %) |
| Dec 22 2020 | NVCR | NovoCure Ltd | Danziger Asaf | Chief Executive Off ... | Sell | S | 162.97 | 1,300 | 211,860 | 199,032 | 200.3 K to 199 K (-0.65 %) |
| Dec 22 2020 | NVCR | NovoCure Ltd | Danziger Asaf | Chief Executive Off ... | Sell | S | 162.17 | 1,426 | 231,259 | 200,332 | 201.8 K to 200.3 K (-0.71 %) |
| Dec 22 2020 | NVCR | NovoCure Ltd | Danziger Asaf | Chief Executive Off ... | Sell | S | 160.99 | 3,500 | 563,479 | 201,758 | 205.3 K to 201.8 K (-1.71 %) |
| Dec 22 2020 | NVCR | NovoCure Ltd | Danziger Asaf | Chief Executive Off ... | Sell | S | 160.25 | 12,092 | 1,937,743 | 205,258 | 217.4 K to 205.3 K (-5.56 %) |
| Dec 22 2020 | NVCR | NovoCure Ltd | Danziger Asaf | Chief Executive Off ... | Sell | S | 159.32 | 4,500 | 716,954 | 217,350 | 221.9 K to 217.4 K (-2.03 %) |
| Dec 22 2020 | NVCR | NovoCure Ltd | Danziger Asaf | Chief Executive Off ... | Sell | S | 158.09 | 9,183 | 1,451,777 | 221,850 | 231 K to 221.9 K (-3.97 %) |
| Dec 22 2020 | NVCR | NovoCure Ltd | Danziger Asaf | Chief Executive Off ... | Sell | S | 157.04 | 24,656 | 3,871,904 | 231,033 | 255.7 K to 231 K (-9.64 %) |
| Dec 22 2020 | NVCR | NovoCure Ltd | Danziger Asaf | Chief Executive Off ... | Sell | S | 156.09 | 24,286 | 3,790,826 | 255,689 | 280 K to 255.7 K (-8.67 %) |
| Dec 22 2020 | NVCR | NovoCure Ltd | Danziger Asaf | Chief Executive Off ... | Sell | S | 155.24 | 21,612 | 3,355,047 | 279,975 | 301.6 K to 280 K (-7.17 %) |
| Dec 22 2020 | NVCR | NovoCure Ltd | Danziger Asaf | Chief Executive Off ... | Buy | M | 22.00 | 103,955 | 2,287,010 | 301,587 | 197.6 K to 301.6 K (+52.60 %) |